Product Images Carisoprodol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Carisoprodol NDC 16571-781 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (100 Tablet Bottle) - carisoprodol fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (100 Tablet Bottle) - carisoprodol fig1

The text describes a Carisoprodol medication with the product details such as NDG number, tablet strength, quantity, dosage information, storage instruction, and distribution details by Rising Pharma Holdings Inc. The medication is made in India and the code is mentioned as TS/DRUGS/19/1993.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 350 mg (100 Tablet Bottle) - carisoprodol fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 350 mg (100 Tablet Bottle) - carisoprodol fig2

This is a description of a medication called Carisoprodol USP 350 mg, sold under the brand name "Rising". The medication comes in the form of tablets, with each bottle containing 100 tablets. The recommended dosage is not provided in this text and must be accessed through the enclosed prescribing information. The tablets should be stored in a cool, dry place and in a tight container. This medicine is manufactured by a pharmaceutical company called Rising Pharma Holdings and has been distributed from East Brunswick, NJ 08816. The text also contains some additional details such as product codes and a printing area.*

str1 - carisoprodol str

str1 - carisoprodol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.